- Home
- PTPI
as 07-26-2024 4:00pm EST
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 3.0M | IPO Year: | N/A |
| Target Price: | $4.00 | AVG Volume (30 days): | 441.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.39 - $4.34 | Next Earning Date: | 08-12-2024 |
| Revenue: | $4,693,224 | Revenue Growth: | -22.36% |
| Revenue Growth (this year): | -5.25% | Revenue Growth (next year): | 1.23% |
Latest Petros Pharmaceuticals Inc. News
PTPI Breaking Stock News: Dive into PTPI Ticker-Specific Updates for Smart Investing
ACCESSWIRE
10 days ago
Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
CNW Group
2 months ago
Start Proud Opens the Market
Associated Press Finance
2 months ago
Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it
Business Wire
2 months ago
Form 8.3 - Darktrace plc
Investor's Business Daily
2 months ago
Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives
Yahoo Finance Video
2 months ago
May jobs reports signals Fed's soft landing: US Labor Secretary
Business Wire
2 months ago
NICE to Webcast Financial Analyst and Investor Day at Interactions 2024
PR Newswire
2 months ago
Notification of major holding in Kindred Group plc
Compare PTPI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PTPI Petros Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.